Singapore: Biolidics raises S$3.13m from private placement

Jeremy Yee, chairman, Biolidics

Cancer diagnostics company Biolidics is to raise S$3.13m (US$2.2m) from a share placement exercise. It intends to issue 17.9 million shares at S$0.175 per share. This is a 7.3% discount to the VWAP on 13 March. The majority of the 21 investors are existing shareholders, including brother and sister investors Thiam Huat Kuik and Kuik…

You must be a HMI Subscriber to view this content.

Subscribe Now »